loading
Precedente Chiudi:
$12.42
Aprire:
$12.58
Volume 24 ore:
1.46M
Relative Volume:
1.09
Capitalizzazione di mercato:
$1.27B
Reddito:
-
Utile/perdita netta:
$-137.25M
Rapporto P/E:
-6.9312
EPS:
-1.89
Flusso di cassa netto:
$-121.97M
1 W Prestazione:
+2.50%
1M Prestazione:
+25.24%
6M Prestazione:
+152.41%
1 anno Prestazione:
+55.21%
Intervallo 1D:
Value
$12.47
$13.38
Intervallo di 1 settimana:
Value
$11.71
$13.38
Portata 52W:
Value
$3.8951
$14.93

Oric Pharmaceuticals Inc Stock (ORIC) Company Profile

Name
Nome
Oric Pharmaceuticals Inc
Name
Telefono
(650) 388-5600
Name
Indirizzo
240 E. GRAND AVE., SOUTH SAN FRANCISCO, CA
Name
Dipendente
128
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-04
Name
Ultimi documenti SEC
Name
ORIC's Discussions on Twitter

Confronta ORIC con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ORIC
Oric Pharmaceuticals Inc
13.10 1.21B 0 -137.25M -121.97M -1.89
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
421.39 108.36B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
463.43 60.82B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
577.95 61.02B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
817.32 50.01B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
310.81 34.05B 4.56B -176.77M 225.30M -1.7177

Oric Pharmaceuticals Inc Stock (ORIC) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-09-04 Ripresa Guggenheim Buy
2025-07-08 Iniziato Ladenburg Thalmann Buy
2024-10-31 Iniziato Wells Fargo Overweight
2024-09-06 Iniziato Stifel Buy
2024-02-23 Iniziato Cantor Fitzgerald Overweight
2023-09-22 Iniziato Wedbush Outperform
2023-03-23 Aggiornamento H.C. Wainwright Neutral → Buy
2023-03-21 Aggiornamento Guggenheim Neutral → Buy
2023-03-16 Aggiornamento Oppenheimer Perform → Outperform
2022-07-18 Ripresa Oppenheimer Perform
2022-04-04 Aggiornamento Citigroup Neutral → Buy
2022-03-25 Downgrade H.C. Wainwright Buy → Neutral
2022-03-22 Downgrade Citigroup Buy → Neutral
2022-03-22 Downgrade Guggenheim Buy → Neutral
2022-03-22 Downgrade Oppenheimer Outperform → Perform
2021-07-06 Aggiornamento Citigroup Neutral → Buy
2021-01-25 Downgrade Citigroup Buy → Neutral
2020-08-13 Iniziato Robert W. Baird Outperform
2020-08-06 Aggiornamento Citigroup Neutral → Buy
2020-08-03 Iniziato H.C. Wainwright Buy
2020-05-19 Iniziato Citigroup Neutral
2020-05-19 Iniziato Guggenheim Buy
2020-05-19 Iniziato JP Morgan Overweight
2020-05-19 Iniziato Jefferies Buy
Mostra tutto

Oric Pharmaceuticals Inc Borsa (ORIC) Ultime notizie

pulisher
Oct 25, 2025

What technical models suggest about ORIC Pharmaceuticals Inc.’s comebackJuly 2025 Sector Moves & Weekly Market Pulse Updates - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Why ORIC Pharmaceuticals Inc. (4TZ) stock stays on top picksTrade Analysis Summary & Weekly Top Performers Watchlists - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Has ORIC Pharmaceuticals Inc. found a price floorJuly 2025 Setups & Technical Confirmation Trade Alerts - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Will ORIC Pharmaceuticals Inc. stock split again soonEarnings Risk Summary & Detailed Earnings Play Alerts - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Relative strength of ORIC Pharmaceuticals Inc. in sector analysisWeekly Gains Summary & AI Forecast for Swing Trade Picks - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Sentiment analysis tools applied to ORIC Pharmaceuticals Inc.July 2025 Retail & Risk Controlled Stock Pick Alerts - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

How to read the order book for ORIC Pharmaceuticals Inc.July 2025 Review & Real-Time Chart Breakout Alerts - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Can you recover from losses in ORIC Pharmaceuticals Inc.2025 Breakouts & Breakdowns & Community Shared Stock Ideas - newser.com

Oct 25, 2025
pulisher
Oct 24, 2025

Oric Pharmaceuticals, Inc. (ORIC) Investor Outlook: A Promising 47% Upside Potential Amid Innovative Cancer Therapies - DirectorsTalk Interviews

Oct 24, 2025
pulisher
Oct 23, 2025

BDTX vs. ORIC: Which Oncology Focused Biotech Stock Is a Better Pick Now? - sharewise.com

Oct 23, 2025
pulisher
Oct 22, 2025

TD Asset Management Inc Raises Position in Oric Pharmaceuticals, Inc. $ORIC - MarketBeat

Oct 22, 2025
pulisher
Oct 21, 2025

Historical volatility pattern of ORIC Pharmaceuticals Inc. visualizedWeekly Profit Report & Verified Technical Trade Signals - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Candlestick signals on ORIC Pharmaceuticals Inc. stock todayEarnings Summary Report & Capital Efficient Trading Techniques - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Analyzing drawdowns of ORIC Pharmaceuticals Inc. with statistical tools2025 Winners & Losers & Weekly Consistent Profit Watchlists - newser.com

Oct 21, 2025
pulisher
Oct 20, 2025

Published on: 2025-10-20 19:38:47 - newser.com

Oct 20, 2025

Oric Pharmaceuticals Inc Azioni (ORIC) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$37.26
price up icon 1.11%
$91.28
price up icon 2.21%
$29.89
price up icon 0.07%
$105.66
price up icon 0.87%
$159.66
price down icon 0.29%
biotechnology ONC
$310.81
price up icon 0.25%
Capitalizzazione:     |  Volume (24 ore):